Company profile: PhyNexus
1.1 - Company Overview
Company description
- Provider of chromatography-enabled pipette tip columns for protein and plasmid purification, delivering high-throughput sample processing for life science researchers in drug discovery, screening, structural studies, and other workflows requiring very pure, highly concentrated products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PhyNexus
Lakewood-Amedex
HQ: United States
Website
- Description: Provider of novel anti-infective therapeutics for serious infectious diseases, including Bisphosphocins, a novel class of antimicrobial agents effective against a wide range of bacteria and fungi, including antibiotic-resistant strains; and Nu-3 gel, a Bisphosphocin gel for treating infected diabetic foot ulcers, advancing into Phase 2 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lakewood-Amedex company profile →
Inari
HQ: United States
Website
- Description: Provider of seed design and biotechnology focused on developing seeds for a nature-positive food system, leveraging predictive design and multiplex gene editing to transform agriculture and its impact on society and the environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inari company profile →
Microarrays
HQ: United States
Website
- Description: Provider of microarray platforms and services for analyte testing, diagnostics, and personalized medicine, including pathway-focused gene expression arrays (MI PathArray), whole-genome microarrays (MI ReadyArray), DNA and protein/antibody arrays, assay development, and lab services for RNA profiling and microarray assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microarrays company profile →
Bamboo Therapeutics
HQ: United States
Website
- Description: Provider of gene therapy development, research, and manufacturing for rare genetic diseases, advancing the work of Dr. Richard Jude Samulski at UNC’s Gene Therapy Center from the laboratory into human clinical trials to meet drug approval requirements. Operates a Sanford, North Carolina manufacturing complex using specialized methodologies and advanced techniques.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bamboo Therapeutics company profile →
Immunostep
HQ: Spain
Website
- Description: Provider of flow chemistry products and services for diagnostic and research applications, including antibodies and conjugates, recombinant proteins, vials, staining solutions, and stability reagents, plus mono- and polyclonal development and peptide production. Offers kits for flow cytometry such as HeMoStep, apoptosis and basophil activation, platelet immunoglobulin and COVID-19 tests, and the ExoStep exosome platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunostep company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PhyNexus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PhyNexus
2.2 - Growth funds investing in similar companies to PhyNexus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PhyNexus
4.2 - Public trading comparable groups for PhyNexus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →